
Annual Report 2022
111
Section 5 - Investment in Trifork Labs
NOTE 5.1
Investments in Trifork Labs (continued)
The realized fair value adjustments are
in relation to exits from investments and
dividend income. The unrealized fair value
adjustments are in relation to new funding
rounds with different valuation of invested
companies, updated business plans leading
to a new valuation or - for Level 1 instruments
- change in market prices.
The fair value of Level 3 investments is de-
rived from DCF-valuation models or recent
transactions (new capital investments by
third parties).
2022
In 2022, new investments were made in
Promon A/S, Feats ApS, TSBThree ApS and
Fauna ApS and existing investments in Arkyn
Studios Ltd., Dryp A/S, Kashet Group AG,
Visikon ApS, &Money ApS and Edia B.V. were
increased. For this, EURk 9,628 were invested
in cash and EURk 787 by conversion of loans.
In the reporting period, the Container
Solutions Group started a reorganization. In
this process, Trifork Group exited its in-
vestment in Programmable Infrastructure
Solutions AG, the former Holding company
of the Group, at the carrying amount of EURk
1,553 (cash consideration) and will keep a
shareholding of approximately 6.2% in the
succeeding Holding company.
In 2022, Trifork Group has received final pay-
ments subsequent to the exit of Humio Ltd. in
2021 of EURk 1,635.
In addition, Atomist Inc. was dissolved and a
payment of EURk 91 was received.
Further, the investment in ComplyTeq AG was
fully impaired as it expects to cease its ac-
tivities. In connection with this, Trifork Group
has also impaired its loan to ComplyTeq AG.
2021
The cash proceeds from the sale of Humio
Ltd. of EURk 57,846 were received at the
beginning of March 2021. As the amount
was fixed in USD the Group recognized an
additional fair value adjustment of EURk 1,740
from foreign exchange gains.
Later in 2021, a payment of EURk 203 for
the sale of Humio Ltd. was received based
on updated calculations as per date of
disposal. This cash in was not expected by
the Group and is recognized as realized fair
value adjustment.
In 2021, the investments in Supertrends AG
and Programmable Infrastructure Solutions
AG were (partially) exited at carrying
amounts of EURk 26 and EURk 350 and
Testlab ApS, Dawn Labs A/S and XCI Holding
A/S were (partially) exited at EURk 634 (of
which EURk 303 were received in treasury
shares).
During 2021, new investments were made
in &Money ApS, Visikon ApS and Develco
A/S and existing investments in Dryp A/S,
Upcycling Forum ApS and Kashet Group AG
were increased , including an execution of a
convertible note in the amount of EURk 68.
Subsequent to the loss of control and
deconsolidation of Dawn Health A/S, the re-
tained investment was transferred to Trifork
Labs segment as of 30 November 2021 (refer
to Note 4.2).
There were no transfers between fair value
measurements levels in 2022 and 2021.
In addition, there are also convertible loans
outstanding with investments in Trifork Labs,
refer to Note 4.3)
!
Significant accounting estimates,
assumptions and judgments
The fair value of level 3 equity investments is
determined based on DCF-valuation models
and/or valuations derived from recent trans-
actions by external parties that have invested
new capital in these companies. A sensitivity
analysis has been performed on this in Note
7.5. Because of the inherent uncertainty of
valuation of private equity in general, the
estimate fair value may differ from the values
that would have been used had an active
market existed for the investments and the
difference regarding individual investments
could be material. Any gain or loss arising
from a change in fair value of investments is
included in separate line item in the income
statement.
§
Accounting policy
Equity investments held by Trifork Labs (the
Group's driver for R&D innovation) are classi-
fied as financial assets at fair value through
profit in accordance with IFRS 9 and the
amendment to IAS 28. Exemptions from Ap-
plying the Equity Method. These venture cap-
ital equity investments are accounted for at
fair value through profit or loss as the Group
elects at initial recognition of the investments
to apply IFRS 9 rather than the equity method
under IAS 28.
Changes in fair value are recognized and
presented separately in the income state-
ment as fair value adjustments on invest-
ments in Trifork Labs.